The buyer requires us to roll twenty percent of our equity into their new holding entity as part of the transaction. What terms and structural safeguards must we negotiate to prevent our rollover equity from being diluted or subordinated to zero?

Question

Tyler Smith · Accepted Answer

Rolling equity into a buyer's new capital structure is common in private equity recapitalizations, but untreated rollover equity carries substantial risk. If you simply accept common shares alongside an aggressive sponsor, your twenty percent stake can be diluted down to irrelevance by future capital calls, management incentive option pools, and layers of senior preferred returns.

To protect the true value of your rollover equity, your definitive purchase agreement must contain specific legal and financial safeguards:
- Insist that your rollover equity is issued pari passu, on identical economic terms and share class, with the sponsor equity, rather than being subordinated to preferred shares with compounding interest rates.
- Demand pre-emptive anti-dilution rights that give you the legal option to participate in future equity rounds on the same terms as institutional investors, preventing arbitrary cram-downs.
- Secure tag-along rights that legally require the buyer to include your shares on the exact same terms if they sell the company, along with clear information rights to receive audited quarterly financials.
- Limit the size of management equity incentive pools to standard ten to fifteen percent thresholds, ensuring the dilution is shared equitably among all original equity holders.

Do not treat rollover equity as funny money or an afterthought. It represents real capital that you are lending to the buyer's growth thesis, and it must be shielded with the same rigor you apply to cash at close.